{"id":"W2800600983","doi":"10.1200/jco.2018.36.4_suppl.435","title":"Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Internal medicine; Performance status; Oncology; Cancer; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001919325,0.0001502504,0.000236978,0.0003334548,0.0002769254,0.0004899729,0.0001716755,0.0003419762,0.001418964],"category_scores_gemma":[0.0008883846,0.00008615818,0.0003122652,0.0005742361,0.000175115,0.0002316718,0.0002081241,0.000426317,0.0002244622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007234993,"about_ca_system_score_gemma":0.0004837884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007532101,"about_ca_topic_score_gemma":0.01101921,"domain_scores_codex":[0.9998795,0.00001337122,0.00001248221,0.00002929746,0.00002998405,0.00003533827],"domain_scores_gemma":[0.9992886,0.0000657563,0.0003691077,0.00001788699,0.00006138702,0.0001972364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001794503,0.00003168816,0.9981765,0.000009087106,0.00002162643,0.0001071661,0.00002172839,0.00005760804,0.0001291025,0.000004652603,0.0001696527,0.001091701],"study_design_scores_gemma":[0.00002020238,0.0001997198,0.9987919,0.000006899948,0.00001754857,0.0005163724,0.00006441879,0.0001356633,0.00004480333,0.00001165264,0.0001884753,0.000002399564],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987841,0.0002349273,0.00002368553,0.00005522409,0.000004264752,0.000006885867,0.0004642348,0.000002614478,0.000424026],"genre_scores_gemma":[0.9990441,0.00007063949,0.00001784858,0.00002997112,0.000007141979,0.000005522027,0.0007038684,8.714887e-7,0.0001200472],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007532101,"threshold_uncertainty_score":0.0149765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.146758172869003,"score_gpt":0.5235647027754803,"score_spread":0.3768065299064773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}